A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

NCT06200467 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

COMBINATION_PRODUCT: BI 456906
COMBINATION_PRODUCT: Placebo to BI 456906
DRUG: Moxifloxacin
DRUG: Placebo to moxifloxacin

Sponsor

Boehringer Ingelheim